glp-1 clinical trials Discover How Are Not One-Size-Fit-All We run “head-to-head” clinical trials

A medication that patients are already motivated to take (because theyre seeing weight loss and metabolic benefits) and that simultaneously reduces alcohol cravings could change the treatment landscape dramatically

How do I know if my GLP-1 has truly stopped working

Clinicians should continue reporting safety concerns and monitoring patient outcomes carefully

Percent Daily Value (DV) Not Established

[DOI] [PMC free article] [PubMed] [Google Scholar] 104.Weir H.J., Yao P., Huynh F.K., Escoubas C.C., Goncalves R.L., Burkewitz K., Laboy R., Hirschey M.D., Mair W.B

We performed metarregression to evaluate if there was a trend towards higher incidence of pancreatic cancer in studies with longer duration, however no association between duration and the outcome was observed